For over half a century, grain refinement of aluminium alloys has been achieved by chemical inoculation; current grain-refinement practice involves the addition of master alloys (e.g. Al -Ti -B, Al -Ti -C) before casting, introducing inoculant particles to the melt. These particles act as nucleation points for a-Al grains, resulting in a uniformly fine, equiaxed as cast microstructure. Despite the ubiquity of this process, its underpinning science was not fully understood, hindering development of the area. From the 1950s onwards, the phase responsible for nucleation in alloys refined by Al -Ti -B was fiercely disputed. The debate focused so closely on this issue that other important factors were frequently ignored. During the 1990s, this debate was resolved through careful thermodynamic reasoning and novel experiments that derived their inspiration far from the foundry. This review focuses on subsequent experimental work and modelling: the expansion of the current understanding of grain refinement to include effects relating to the release of latent heat, the size distribution of inoculant particles and the alloying elements present in the melt (through poisoning and growth-restriction effects). The current contention regarding the nature of the interface between the nucleant phase (TiB 2 ) and the melt is also discussed. These recent advancements have lead to improvements in grain refining practice resulting in savings in the foundry and development of alternative master alloys for aluminium systems. The ideas have also been successfully applied to other metallic systems, notably magnesium and zinc alloys.* MST/6285
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.